EP Patent

EP0832880B1 — Dihydrobenzofluorene compounds, intermediates, compositions, and methods

Assigned to Eli Lilly and Co · Expires 2003-07-02 · 23y expired

What this patent protects

The invention provides dihydronbenzofluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions.

USPTO Abstract

The invention provides dihydronbenzofluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0832880B1
Jurisdiction
EP
Classification
—
Expires
2003-07-02
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.